199 related articles for article (PubMed ID: 28978570)
21. Super Enhancer Regulatory Gene FYB1 Promotes the Progression of T Cell Acute Lymphoblastic Leukemia by Activating IGLL1.
Zhang K; Lu J; Fang F; Zhang Y; Yu J; Tao Y; Liu W; Lu L; Zhang Z; Chu X; Wang J; Li X; Tian Y; Li Z; Li Q; Sang X; Ma L; Wang N; Pan J; Hu S
J Immunol Res; 2023; 2023():3804605. PubMed ID: 37767202
[TBL] [Abstract][Full Text] [Related]
22. dbSUPER: a database of super-enhancers in mouse and human genome.
Khan A; Zhang X
Nucleic Acids Res; 2016 Jan; 44(D1):D164-71. PubMed ID: 26438538
[TBL] [Abstract][Full Text] [Related]
23. Super-enhancer-driven expression of BAHCC1 promotes melanoma cell proliferation and genome stability.
Berico P; Nogaret M; Cigrang M; Lallement A; Vand-Rajabpour F; Flores-Yanke A; Gambi G; Davidson G; Seno L; Obid J; Vokshi BH; Le Gras S; Mengus G; Ye T; Cordero CF; Dalmasso M; Compe E; Bertolotto C; Hernando E; Davidson I; Coin F
Cell Rep; 2023 Nov; 42(11):113363. PubMed ID: 37924516
[TBL] [Abstract][Full Text] [Related]
24. Super enhancers: Pathogenic roles and potential therapeutic targets for acute myeloid leukemia (AML).
Cao Z; Shu Y; Wang J; Wang C; Feng T; Yang L; Shao J; Zou L
Genes Dis; 2022 Nov; 9(6):1466-1477. PubMed ID: 36157504
[TBL] [Abstract][Full Text] [Related]
25. A holistic view of mouse enhancer architectures reveals analogous pleiotropic effects and correlation with human disease.
Sethi S; Vorontsov IE; Kulakovskiy IV; Greenaway S; Williams J; Makeev VJ; Brown SDM; Simon MM; Mallon AM
BMC Genomics; 2020 Nov; 21(1):754. PubMed ID: 33138777
[TBL] [Abstract][Full Text] [Related]
26. Landscape of enhancer disruption and functional screen in melanoma cells.
Wang Z; Luo M; Liang Q; Zhao K; Hu Y; Wang W; Feng X; Hu B; Teng J; You T; Li R; Bao Z; Pan W; Yang T; Zhang C; Li T; Dong X; Yi X; Liu B; Zhao L; Li M; Chen K; Song W; Yang J; Li MJ
Genome Biol; 2023 Oct; 24(1):248. PubMed ID: 37904237
[TBL] [Abstract][Full Text] [Related]
27. Super enhancer inhibitors suppress MYC driven transcriptional amplification and tumor progression in osteosarcoma.
Chen D; Zhao Z; Huang Z; Chen DC; Zhu XX; Wang YZ; Yan YW; Tang S; Madhavan S; Ni W; Huang ZP; Li W; Ji W; Shen H; Lin S; Jiang YZ
Bone Res; 2018; 6():11. PubMed ID: 29644114
[TBL] [Abstract][Full Text] [Related]
28. Cell-specific and shared enhancers control a high-density multi-gene locus active in mammary and salivary glands.
Lee HK; Willi M; Liu C; Hennighausen L
bioRxiv; 2023 Feb; ():. PubMed ID: 36945503
[TBL] [Abstract][Full Text] [Related]
29. Cell-specific and shared enhancers control a high-density multi-gene locus active in mammary and salivary glands.
Hennighausen L; Lee HK; Willi M; Liu C
Res Sq; 2023 Feb; ():. PubMed ID: 36789414
[TBL] [Abstract][Full Text] [Related]
30. A network biology approach evaluating the anticancer effects of bortezomib identifies SPARC as a therapeutic target in adult T-cell leukemia cells.
Ohyashiki JH; Hamamura R; Kobayashi C; Zhang Y; Ohyashiki K
Adv Appl Bioinform Chem; 2008; 1():85-98. PubMed ID: 21918608
[TBL] [Abstract][Full Text] [Related]
31. From Genotype to Phenotype: How Enhancers Control Gene Expression and Cell Identity in Hematopoiesis.
Mulet-Lazaro R; Delwel R
Hemasphere; 2023 Nov; 7(11):e969. PubMed ID: 37953829
[TBL] [Abstract][Full Text] [Related]
32. Tucidinostat restores CCR4 expression in adult T-cell leukemia/lymphoma.
Kawata T; Shimizu T; Shindo T; Fujiwara K; Morimoto S; Watanabe M
Haematologica; 2024 Mar; 109(3):1007-1009. PubMed ID: 37794797
[No Abstract] [Full Text] [Related]
33. Cyclin-dependent kinase 7 inhibitor THZ1 in cancer therapy.
Li BB; Wang B; Zhu CM; Tang D; Pang J; Zhao J; Sun CH; Qiu MJ; Qian ZR
Chronic Dis Transl Med; 2019 Sep; 5(3):155-169. PubMed ID: 31891127
[TBL] [Abstract][Full Text] [Related]
34.
Hosoi H; Tabata S; Kosako H; Hori Y; Okamura T; Yamashita Y; Fujimoto K; Kajioka D; Suzuki K; Osato M; Yamada G; Sonoki T
Leuk Res Rep; 2024; 21():100451. PubMed ID: 38444524
[No Abstract] [Full Text] [Related]
35. Super-enhancer landscape rewiring in cancer: The epigenetic control at distal sites.
Di Giorgio E; Benetti R; Kerschbamer E; Xodo L; Brancolini C
Int Rev Cell Mol Biol; 2023; 380():97-148. PubMed ID: 37657861
[TBL] [Abstract][Full Text] [Related]
36. Pathogenic role of super-enhancers as potential therapeutic targets in lung cancer.
Yao Z; Song P; Jiao W
Front Pharmacol; 2024; 15():1383580. PubMed ID: 38681203
[TBL] [Abstract][Full Text] [Related]
37. Super-Enhancers in the Regulation of Gene Transcription: General Aspects and Antitumor Targets.
Bruter AV; Rodionova MD; Varlamova EA; Shtil AA
Acta Naturae; 2021; 13(1):4-15. PubMed ID: 33959383
[TBL] [Abstract][Full Text] [Related]
38. Dissecting and redesigning enhancers of photosynthesis genes.
Liu P
Plant Cell; 2024 Apr; ():. PubMed ID: 38648514
[No Abstract] [Full Text] [Related]
39. Suppression of Adaptive Responses to Targeted Cancer Therapy by Transcriptional Repression.
Rusan M; Li K; Li Y; Christensen CL; Abraham BJ; Kwiatkowski N; Buczkowski KA; Bockorny B; Chen T; Li S; Rhee K; Zhang H; Chen W; Terai H; Tavares T; Leggett AL; Li T; Wang Y; Zhang T; Kim TJ; Hong SH; Poudel-Neupane N; Silkes M; Mudianto T; Tan L; Shimamura T; Meyerson M; Bass AJ; Watanabe H; Gray NS; Young RA; Wong KK; Hammerman PS
Cancer Discov; 2018 Jan; 8(1):59-73. PubMed ID: 29054992
[TBL] [Abstract][Full Text] [Related]
40. Prognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma.
Kataoka K; Iwanaga M; Yasunaga JI; Nagata Y; Kitanaka A; Kameda T; Yoshimitsu M; Shiraishi Y; Sato-Otsubo A; Sanada M; Chiba K; Tanaka H; Ochi Y; Aoki K; Suzuki H; Shiozawa Y; Yoshizato T; Sato Y; Yoshida K; Nosaka K; Hishizawa M; Itonaga H; Imaizumi Y; Munakata W; Shide K; Kubuki Y; Hidaka T; Nakamaki T; Ishiyama K; Miyawaki S; Ishii R; Nureki O; Tobinai K; Miyazaki Y; Takaori-Kondo A; Shibata T; Miyano S; Ishitsuka K; Utsunomiya A; Shimoda K; Matsuoka M; Watanabe T; Ogawa S
Blood; 2018 Jan; 131(2):215-225. PubMed ID: 29084771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
